Pre-Exposure Prophylaxis

"Pre-Exposure Prophylaxis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A method of disease prevention (abbreviated PrEP) which involves the administration of drugs to at-risk persons who have not been exposed to the disease-causing agent.

Descriptor ID	D065129
MeSH Number(s)	N02.421.726.758.655 N06.850.780.680.655
Concept/Terms	Pre-Exposure Prophylaxis Pre-Exposure Prophylaxis Pre Exposure Prophylaxis Pre-Exposure Prophylaxi Prophylaxi, Pre-Exposure Prophylaxis, Pre-Exposure Pre-Exposure Prophylaxis (PrEP) Pre Exposure Prophylaxis (PrEP) Pre-Exposure Prophylaxi (PrEP) Prophylaxi, Pre-Exposure (PrEP) Prophylaxis, Pre-Exposure (PrEP)

Below are MeSH descriptors whose meaning is more general than "Pre-Exposure Prophylaxis".

Health Care [N]
Health Care Facilities, Manpower, and Services [N02]
Health Services [N02.421]
Preventive Health Services [N02.421.726]
Primary Prevention [N02.421.726.758]
Pre-Exposure Prophylaxis [N02.421.726.758.655]
Environment and Public Health [N06]
Public Health [N06.850]
Public Health Practice [N06.850.780]
Primary Prevention [N06.850.780.680]
Pre-Exposure Prophylaxis [N06.850.780.680.655]

Below are MeSH descriptors whose meaning is related to "Pre-Exposure Prophylaxis".

Below are MeSH descriptors whose meaning is more specific than "Pre-Exposure Prophylaxis".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Pre-Exposure Prophylaxis" by people in this website by year, and whether "Pre-Exposure Prophylaxis" was a major or minor topic of these publications.

Bar chart showing 22 publications over 9 distinct years, with a maximum of 7 publications in 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2015	1	0	1
2016	1	0	1
2018	1	0	1
2019	2	0	2
2020	1	1	2
2021	2	1	3
2022	7	0	7
2023	1	1	2
2024	3	0	3

Below are the most recent publications written about "Pre-Exposure Prophylaxis" by people in Profiles.

Chai PR, Goodman GR, Mohamed Y, Bustamante MJ, Albrechta H, Lee JS, Glynn TR, Boland K, Hokayem J, Boyer EW, Rosen RK, Mayer KH, O'Cleirigh C. Leveraging A Digital Pill System to Understand Prevention-Effective Adherence to Oral Hiv Pre-Exposure Prophylaxis Among Men Who Have Sex with Men with Substance Use. AIDS Behav. 2024 Oct; 28(10):3373-3380.

View in: PubMed
Yu YJ, Schieber E, Janamnuaysook R, Wang B, Gunasekar A, MacDonell K, Getwongsa P, Kim D, Wongharn P, Phanuphak N. Barriers and facilitators to pre-exposure prophylaxis (PrEP) uptake and adherence among men who have sex with men (MSM) in Thailand: a qualitative study. AIDS Care. 2024 Aug; 36(8):1126-1134.

View in: PubMed
Janamnuaysook R, Guo Y, Yu YJ, Phanuphak N, Kawichai S, MacDonell K, Jupimai T, Rongkavilit C, Wang B. Lived experiences with pre-exposure prophylaxis uptake and adherence among transgender women in Thailand: a qualitative study. Sex Health. 2024 Jan; 21.

View in: PubMed
Aggarwal A, Zhang R, Qiao S, Wang B, Lwatula C, Menon A, Ostermann J, Li X, Harper G. Physician-Patient Interaction Quality Mediates the Association Between HIV-Related Stigma and HIV-Prevention Behaviors Among Sexual Minority Men in Zambia. AIDS Behav. 2024 May; 28(5):1559-1569.

View in: PubMed
Donnell D, Gao F, Hughes JP, Hanscom B, Corey L, Cohen MS, Edupuganti S, Mgodi N, Rees H, Baeten JM, Gray G, Bekker LG, Hosseinipour M, Delany-Moretlwe S. Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women. J Int AIDS Soc. 2023 06; 26(6):e26118.

View in: PubMed
Chai P, De D, Albrechta H, Goodman GR, Takabatake K, Ben-Arieh A, Lee JS, Glynn TR, Mayer K, O'Cleirigh C, Fisher C. Attitudes towards participating in research involving digital pill systems to measure oral HIV pre-exposure chemoprophylaxis: a cross-sectional study among men who have sex with men with substance use in the USA. BMJ Open. 2023 01 30; 13(1):e067549.

View in: PubMed
Doan AH, Vu CMH, Nguyen TT, Green KE, Phan HTT, Janamnuaysook R, Vu BN, Le TM, Do KQ, Tran TT, Ngo TM, Basu L, Tran LK, Humeau Z. Caring for the whole person: transgender-competent HIV pre-exposure prophylaxis as part of integrated primary healthcare services in Vietnam. J Int AIDS Soc. 2022 10; 25 Suppl 5:e25996.

View in: PubMed
Goodman GR, Vaz C, Albrechta H, Boyer EW, Mayer KH, O'Cleirigh C, Chai PR. Ingestible Electronic Sensors for Monitoring Real-time Adherence to HIV Pre-exposure Prophylaxis and Antiretroviral Therapy. Curr HIV/AIDS Rep. 2022 10; 19(5):433-445.

View in: PubMed
Argenyi MS, Molotnikov LE, Leach DH, Roosevelt KA, Klevens RM, Hsu KK. Gaps in HIV Preexposure Prophylaxis Continuum of Care Following State Partner Services for Massachusetts Primary and Secondary Syphilis Cases, 2017 to 2018. Sex Transm Dis. 2022 09 01; 49(9):657-661.

View in: PubMed
Eshleman SH, Fogel JM, Piwowar-Manning E, Chau G, Cummings V, Agyei Y, Richardson P, Sullivan P, Haines CD, Bushman LR, Petropoulos C, Persaud D, Kofron R, Hendrix CW, Anderson PL, Farrior J, Mellors J, Adeyeye A, Rinehart A, St Clair M, Ford S, Rooney JF, Mathew CA, Hunidzarira P, Spooner E, Mpendo J, Nair G, Cohen MS, Hughes JP, Hosseinipour M, Hanscom B, Delany-Moretlwe S, Marzinke MA. Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084. J Infect Dis. 2022 05 16; 225(10):1741-1749.

View in: PubMed

People

Explore

Similar Concepts

Top Journals